drugset / Trial / NCT00733473

Nebulized Budesonide for Children Who Are Hospitalized for Acute Wheezing

NCT00733473

Phase 4 Completed 100 enrolled Kecioren Education and Training Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine if adding nebulized budesonide to the systemic steroid for treatment of acute wheezing has any additive benefit in children who have hospitalized for acute wheezing.

Timeline

Start
2007-09
Primary completion
2009-12
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Budesonide Small molecule 1 mg Other

Indications